EHA-EBMT 2nd European CAR T Cell Meeting
Dates: January 30 – February 1, 2020
Location: Sitges (Barcelona), Spain
Chairs: H Einsele, C Chabannon
The 2nd edition of this meeting is jointly organized by the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT).
Registration for the 2nd European CAR T Cell Meeting has sold out and it is no longer possible to attend the meeting in person.
Online live-stream registration is officially open Register here
The recent approval of the first CAR T cell treatments in Europe presents a great opportunity to fight hematological malignancies, but also poses serious challenges given the peculiar nature of the treatment. Patients, physicians, nurses, hospitals and whole health systems need to learn how to select the right treatments, handle specific toxicities, organize treatment units and cope with the increasing costs connected with CAR T therapy.
This meeting will build on the knowledge and experience shared at the first joint meeting and will see the return of a number of KOL’s to give updates on the rapid developments in this exciting therapy. The program will include a comprehensive outlook on the current research efforts in Europe, the USA and China to increase CAR T cell therapies efficacy and targets, with input from basic researchers as well as representatives from the industry.
EHA Topics-in-Focus Immunotherapy
This meeting is part of the Topics-in-Focus program on Immunotherapy, launched by the EHA Board at EHA23.
This program is aimed at raising awareness, providing education, furthering research and building a network of experts with the ultimate goal to improve patient care.
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organization representatives.
The program will cover various CAR T Cell related topics, presented from perspectives in Europe, the USA and Asia. Topics and full program can be found here.
Regulatory workshop on the development of CAR T cells
A regulatory workshop on the development of CAR-T Cells will be organized by the consortia EURE-CART and CARAMBA on January 30, 2020. This workshop will take place the morning prior to the 2nd European CAR T Cell meeting, in the same meeting venue, the Melia Sitges Hotel. For more information and to register for the workshop, please visit this website.
Please note: registration for the 2nd European CAR T Cell Meeting is NOT included in the registration for the workshop and must be done separately.
Abstract & case submission
Abstract and case submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers.
Abstract submission has closed.
Venue & Accommodation
The meeting will take place at Melia Sitges Hotel:
Carrer de Joan Salvat Papasseit 38
08870 Sitges (Barcelona), Spain
Accommodation options will be shared shortly.
Online live-stream registration is now open.
This meeting is supported by:
Supreme level partner
Premium level partner
There are various opportunities to support this meeting. For more information please send an email to email@example.com to indicate your interest.
Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.